Determining whether two types of immune cells — T follicular helper cells and activated dendritic cells — are present or lacking in a thymoma, in addition to the levels of specific genes, may help to predict the risk of myasthenia gravis (MG) among people with these tumors, a small study suggests. The study, “Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma,” was published in…

You must be logged in to read/download the full post.